Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia

John R. Laird

Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia

John R. Laird

Research output: Contribution to journal › Article › peer-review

Abstract

The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.

Original language	English (US)
Pages (from-to)	757-762
Number of pages	6
Journal	Journal of Invasive Cardiology
Volume	11
Issue number	12
State	Published - 1999
Externally published	Yes

Keywords

Peripheral vascular disease
Thrombolysis

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia'. Together they form a unique fingerprint.

Cite this

@article{d8a642df61a14c4ba5ad1b6b75ee218a,

title = "Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia",

abstract = "The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.",

keywords = "Peripheral vascular disease, Thrombolysis",

author = "Laird, {John R.}",

year = "1999",

language = "English (US)",

volume = "11",

pages = "757--762",

journal = "Journal of Invasive Cardiology",

issn = "1042-3931",

publisher = "HMP Communications",

number = "12",

}

TY - JOUR

T1 - Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia

AU - Laird, John R.

PY - 1999

Y1 - 1999

N2 - The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.

AB - The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.

KW - Peripheral vascular disease

KW - Thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=0000271579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000271579&partnerID=8YFLogxK

M3 - Article

C2 - 10745480

AN - SCOPUS:0000271579

VL - 11

SP - 757

EP - 762

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 12

ER -

Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this